![](https://ml.globenewswire.com/media/ce030f54-e24a-43f4-8194-9d48c8a7d87d/small/vyne-corplogo-rgb-regtm-jpg.jpg)
VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clinical Development
BRIDGEWATER, N.J., July 09, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated therapies for the treatment of immuno- …